PDEX

+ Watchlist + Portfolio

Pro-Dex, Inc.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $65.36
52-Week Range: $23.47 – $77.00
Market Cap: $205.24M
P/E (TTM): 15.55
EPS (TTM): 4.12
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 4.29
PEG Ratio: —
Return on Equity: 32.43%
Return on Assets: 11.97%
Gross Margin: 31.38%
Operating Margin: 17.29%
Profit Margin: 17.62%
Current Ratio: 4.10
Debt/Equity: 0.40
Total Debt: $18.94M
Free Cash Flow: $5.40M
Revenue Growth: 16.60%
Earnings Growth: 143.40%
Enterprise Value: $214.84M

PDEX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$42.04M	$46.09M	$53.84M	$66.59M	$77.55M
Cost of Revenue	$28.91M	$33.34M	$39.29M	$47.08M	$53.21M
Gross Profit	$13.13M	$12.75M	$14.55M	$19.51M	$24.34M
Research & Development	$2.98M	$2.80M	$3.19M	$3.64M	$3.35M
Selling, General & Admin	$4.99M	$4.18M	$4.19M	$5.18M	$8.00M
Operating Expenses	$7.97M	$6.99M	$7.38M	$8.82M	$11.34M
Operating Income	$5.16M	$5.76M	$7.17M	$10.69M	$12.99M
EBITDA	$6.88M	$10.82M	$4.35M	$14.13M	$20.22M
Pretax Income	$5.69M	$9.43M	$2.63M	$12.06M	$18.02M
Income Tax	$1.12M	$2.35M	$507.00K	$3.08M	$4.35M
Net Income	$4.57M	$7.07M	$2.13M	$8.98M	$13.66M
Diluted EPS	1.02	1.95	0.60	2.67	4.12
Diluted Shares	3.76M	3.64M	3.57M	3.36M	3.32M

PDEX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$849.00K	$2.94M	$2.63M	$419.00K	$8.19M
Receivables	$15.38M	$9.95M	$13.89M	$17.49M	$21.82M
Inventory	$12.68M	$16.17M	$15.27M	$22.21M	$21.46M
Current Assets	$31.17M	$30.98M	$36.61M	$47.30M	$53.25M
Total Assets	$49.09M	$51.82M	$52.48M	$61.19M	$74.51M
Current Liabilities	$11.35M	$9.68M	$12.89M	$14.63M	$12.98M
Long-Term Debt	$10.25M	$8.91M	$7.54M	$9.25M	$13.27M
Total Debt	$15.97M	$14.79M	$13.55M	$16.58M	$18.94M
Total Liabilities	$23.66M	$20.23M	$21.61M	$24.56M	$26.88M
Retained Earnings	$17.75M	$24.82M	$26.95M	$35.93M	$47.63M
Shareholders' Equity	$25.43M	$31.59M	$30.87M	$36.63M	$47.63M
Working Capital	$19.81M	$21.30M	$23.72M	$32.67M	$40.27M
Net Debt	$12.69M	$9.80M	$9.28M	$14.97M	$9.28M

PDEX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	-$847.00K	$5.46M	$6.22M	-$1.68M	$7.24M
Capital Expenditure	-$1.67M	-$974.00K	-$983.00K	-$1.25M	-$483.00K
Free Cash Flow	-$2.52M	$4.49M	$5.24M	-$2.93M	$6.76M
Depreciation & Amortisation	$726.00K	$857.00K	$1.16M	$1.24M	$1.39M
Stock-Based Compensation	$1.27M	$766.00K	$605.00K	$555.00K	$688.00K
Investing Cash Flow	-$1.24M	-$885.00K	-$2.23M	-$238.00K	$3.91M
Financing Cash Flow	-$790.00K	-$2.49M	-$4.30M	-$292.00K	-$3.38M
Share Repurchases	-$1.61M	-$1.55M	-$3.50M	-$3.50M	-$3.41M
Net Change in Cash	-$2.87M	$2.09M	-$305.00K	-$2.21M	$7.77M

PDEX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$17.41M	$17.49M	$18.53M	$18.66M	$19.95M	$20.41M
Cost of Revenue	$11.62M	$14.00M	$13.16M	$12.92M	$13.82M	$13.31M
Gross Profit	$5.80M	$3.49M	$5.37M	$5.74M	$6.13M	$7.09M
Research & Development	$947.00K	$905.00K	$768.00K	$734.00K	$827.00K	$1.02M
Selling, General & Admin	$1.21M	$1.24M	$1.49M	$1.75M	$2.21M	$2.54M
Operating Expenses	$2.16M	$2.15M	$2.26M	$2.48M	$3.04M	$3.56M
Operating Income	$3.64M	$1.34M	$3.11M	$3.26M	$3.09M	$3.53M
EBITDA	$5.11M	$2.14M	$6.73M	$3.38M	$5.90M	$4.20M
Pretax Income	$4.55M	$1.60M	$6.22M	$2.93M	$5.34M	$3.52M
Income Tax	$1.28M	$402.00K	$1.54M	$741.00K	$1.40M	$668.00K
Net Income	$3.27M	$1.20M	$4.68M	$2.19M	$3.94M	$2.86M
Diluted EPS	0.98	0.36	1.40	0.66	1.20	—
Diluted Shares	3.34M	3.35M	3.34M	3.30M	3.27M	—

PDEX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$4.47M	$419.00K	$514.00K	$7.95M	$9.99M	$8.19M
Receivables	$15.86M	$17.49M	$18.34M	$18.15M	$19.77M	$21.82M
Inventory	$23.43M	$22.21M	$21.56M	$21.71M	$22.36M	$21.46M
Current Assets	$49.94M	$47.30M	$50.72M	$49.19M	$53.71M	$53.25M
Total Assets	$64.27M	$61.19M	$64.30M	$62.26M	$74.98M	$74.51M
Current Liabilities	$18.32M	$14.63M	$13.60M	$12.20M	$14.64M	$12.98M
Long-Term Debt	$9.86M	$9.25M	$8.63M	$8.01M	$14.30M	$13.27M
Total Debt	$19.10M	$16.58M	$13.79M	$10.89M	$19.33M	$18.94M
Total Liabilities	$28.99M	$24.56M	$22.79M	$20.63M	$29.78M	$26.88M
Retained Earnings	$34.73M	$35.93M	$40.61M	$41.63M	$45.20M	$47.63M
Shareholders' Equity	$35.28M	$36.63M	$41.51M	$41.63M	$45.20M	$47.63M
Working Capital	$31.63M	$32.67M	$37.12M	$36.98M	$39.07M	$40.27M
Net Debt	$13.82M	$14.97M	$12.73M	$2.52M	$8.50M	$9.28M

PDEX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$754.00K	-$173.00K	$2.31M	$3.57M	$1.63M	-$273.00K
Capital Expenditure	-$180.00K	-$93.00K	—	—	-$112.00K	-$203.00K
Free Cash Flow	$574.00K	-$266.00K	$2.31M	$3.40M	$1.52M	-$476.00K
Depreciation & Amortisation	$310.00K	$314.00K	$311.00K	$314.00K	$363.00K	$406.00K
Stock-Based Compensation	$158.00K	$154.00K	$161.00K	$164.00K	$186.00K	$177.00K
Investing Cash Flow	$1.73M	-$992.00K	-$98.00K	$8.87M	-$5.05M	$198.00K
Financing Cash Flow	$1.93M	-$2.89M	-$2.12M	-$5.00M	$5.46M	-$1.73M
Share Repurchases	$0.00	$0.00	$0.00	-$2.21M	-$601.00K	-$600.00K
Net Change in Cash	$4.41M	-$4.05M	$95.00K	$7.44M	$2.04M	-$1.80M

Market Snapshot

About

Pro-Dex designs, develops, and manufactures powered surgical instruments and rotary drive systems for the medical device and dental industries. Products include handpieces, motors, and accessories used in orthopedic, oral, and maxillofacial surgical procedures. The company also serves industrial markets with precision rotary tools.